JLL UK Clustering Insights

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by John O’Driscoll, Global CIO & Head of Investment at AXA Investment Managers – Real Assets.

In the podcast they discuss AXA IM’s ambition and vision in the life sciences sector, focusing specifically on how ESG and societal benefit are key drivers in their investment decisions.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Michael Skynner, Chief Technology Officer, and Richard Hughes, VP of IT, Informatics & Facilities, at Bicycle Therapeutics.

In the podcast they discuss how the demand profile of life science companies changes as their businesses mature, and how real estate decisions are now primarily based on the desires and needs of employees in the post-pandemic world.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Neelam Patel, CEO of MedCity, the life sciences cluster organisation for London, which plays a pivotal role in bridging industry, NHS and academia to boost innovation and economic growth. In the podcast they discuss the challenges facing the life sciences industry from the point of view of the supply and demand of real estate – and explore some of the solutions MedCity are currently working on to help solve the problem, both in London and beyond.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Stanhope’s Charles Walford, Development Director & Head of Life Sciences, to discuss Stanhope’s approach to the occupier market in the Life Sciences sector. With space at a premium in London and the Golden Triangle, they delve into what the emerging trends are – and how those trends influence both design and the provision of space in this competitive market.

“Today’s science deserves a better lab; we got tired of waiting so

we created it”. In our latest podcast, Chris Walters, JLL’s Head of UK Life

Sciences, is joined by SmartLabs’ Amrit Chauduri, CEO, to discuss how and why

SmartLabs was created in the US. With flexibility of lab space top of the

agenda for many in the biotech industry, they delve into how SmartLabs has been

able to help companies build the best infrastructure for their needs – in a

market that is in a constant state of change.

In this episode Chris Walters, JLL’s Head of UK Life Sciences is joined by Harwell’s Stuart Grant, CEO and Dr Barbara Ghinelli, Director, Harwell Campus Business Development to discuss the future of Harwell Campus, the UK’s home for innovation. They delve into the importance of collaboration in creating connected clusters and how Harwell has successfully combined academia, businesses and government investment in one location to become a beacon of global science and discovery.

Travis McCready, Executive Director for US Life Sciences Markets at JLL joins our Head of Life Sciences, Dr Glenn Crocker in this episode to discuss the life sciences market in the United States and the impact that the global pandemic has had on the sector. 

Pete Wilder, Head of Property at Oxford Sciences Innovation (OSI) joins Chris Walters, Investor & Developer Life Sciences Lead in this episode to provide us with an inside view on the future of the Life Sciences market and its physical real estate needs.